The first data that correlate fibrinolytic system to AE pathophysiology date back to 1985, when Nilsson T. et al. showed a constantly fibrinolysis activation during acute attacks in patients with hereditary angioedema with C1-INH deficiency (C1-INH-HAE) [71]. This evidence concerns the gene SERPING1 and hereditary angioedema.